750 Battery Street, 6th Floor
About SavonixSavonix delivers the world's first mobile, evidence-based assessment of cognitive and emotional function. The digital screen is a 30-minute assessment accessed from any iOS or Android device, available via license with healthcare organizations and other third-party partners. Savonix is an accurate, accessible, actionable and affordable tool for professional cognitive screening, empowering healthcare providers to evaluate and leverage results to improve health and treatment outcomes.
Founder & CEO: Mylea Charvat
COO: David Cooper
VP, Product: Devin Seto
Please click here for Savonix's job opportunities.
11 articles with Savonix
Savonix and Fujitsu Connected Technologies Limited Partner to Introduce Savonix Mobile App on Raku-Raku Smartphone F-42A
Savonix , a global leader in digital cognitive health testing, and Fujitsu Connected Technologies Limited (FCNT) , one of the major smartphone manufacturers in Japan, unveiled Savonix Mobile–a digital cognitive testing app–on the Raku-Raku Smartphone F-42A. More than 4.6 million people in Japan are suffering from some form of dem
11/11/2019It was a busy week for clinical trial updates for the first week of November. Here’s a look.
Bayer Selects Savonix Digital Cognitive Assessment Platform to Validate the Effects of Multivitamin Supplement Berocca in Malaysia
Savonix, a global leader in digital tests for cognitive health, and Bayer’s Consumer Health Division today announced a partnership agreement to work together to validate the effects of Bayer’s multivitamin supplement Berocca in the Malaysian market.
Savonix, a global leader in digital tests for cognitive health, announced that the company has published a research paper in the peer-reviewed medical journal Cognition, Brain, Behavior.
Savonix Announces Poster Presentation at the 2019 Alzheimer’s Association International Conference (AAIC)
AAIC is the premier annual conference for presentation and discussion of the latest Alzheimer’s and dementia research.
Savonix announced that the company will present at the upcoming MedTech Innovator 2019 Global Showcase at the Wilson Sonsini Goodrich & Rosati 27th Annual Medical Device Conference on Friday, June 21, 2019 in San Francisco, CA.
May 20, 3:30 PM - 7:00 PM, Poster Author Discussion Hour: 6:00 PM - 7:00 PM
Savonix, a global leader in cognitive health, today announced the successful completion of $9.6M in Series A extension financing, bringing the total round to $14.7M.
Savonix announced it has been selected to join StartUp Health’s global network and portfolio of health innovation companies.
Showcase Held During J.P. Morgan Healthcare Conference in San Francisco
Savonix announced that Dr. Mylea Charvat, CEO and Founder, will present at the Digital Medicine & Medtech Showcase ™ 2018 Conference to be held January 8-10, 2018 in San Francisco, CA.